Use of lanreotide for the treatment of gastrointestinal fistulae.
Kevin
K
Clive
Mark
M
Hardin
Chris
C
White
Claire
C
Larson
John
J
Oh
Stephen
S
Cohn
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007412:Intestinal Fistula / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin